US equities
|
NVDA
$237.81
▲+1.65%
SPCX
$167.86
▲+5.60%
MU
$1,063.32
▼-1.08%
TSLA
$378.97
▲+2.26%
MSFT
$525.03
▲+1.45%
SNDK
$1,710.91
▼-0.53%
INTC
$116.98
▼-1.97%
META
$742.22
▲+1.94%
NVDA
$237.81
▲+1.65%
SPCX
$167.86
▲+5.60%
MU
$1,063.32
▼-1.08%
TSLA
$378.97
▲+2.26%
MSFT
$525.03
▲+1.45%
SNDK
$1,710.91
▼-0.53%
INTC
$116.98
▼-1.97%
META
$742.22
▲+1.94%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Privia Health Group, Inc. - Common Stock
(NQ:
PRVA
)
20.32
+0.02 (+0.12%)
Delayed Quote
Updated: 2:11 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Privia Health Group, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
2 Growth Stocks to Stash and 1 We Turn Down
September 30, 2026
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...
Via
StockStory
Topics
Energy
1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore
September 16, 2026
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Via
StockStory
Topics
Credit Cards
3 Out-of-Favor Stocks We’re Skeptical Of
September 14, 2026
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co...
Via
StockStory
Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest
September 09, 2026
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Privia Health (NASDAQ...
Via
StockStory
Privia Health Group (NASDAQ:PRVA) Jumps on Q2 Revenue Beat
↗
August 06, 2026
Via
Chartmill
Privia Health Group Inc (NASDAQ:PRVA) Q1 Revenue Beats Expectations but EPS Misses Weigh on Results
↗
May 07, 2026
Via
Chartmill
1 Cash-Producing Stock for Long-Term Investors and 2 Facing Challenges
September 03, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
Via
StockStory
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Avoid
August 28, 2026
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via
StockStory
Privia Health (PRVA): Buy, Sell, or Hold Post Q2 Earnings?
August 20, 2026
Privia Health has been treading water for the past six months, recording a small loss of 1.7% while holding steady at $21.63. The stock also fell short of th...
Via
StockStory
Topics
Supply Chain
Privia Health (PRVA) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Net income surged 237% while attributed lives grew 19%, signaling strong operational momentum.
Via
The Motley Fool
Topics
Earnings
The Top 5 Analyst Questions From Privia Health’s Q2 Earnings Call
August 13, 2026
Privia Health’s second quarter results were met with a negative market reaction as investors digested the company’s strong revenue growth alongside a materia...
Via
StockStory
Topics
Artificial Intelligence
Earnings
Privia Health Group Q2 Earnings Call Highlights
↗
August 07, 2026
Privia Health Group (NASDAQ:PRVA) reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from...
Via
MarketBeat
Topics
Earnings
PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus
August 07, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 21.4% year on year to $632.6 mi...
Via
StockStory
Topics
Artificial Intelligence
Privia Health (NASDAQ:PRVA) Surprises With Q2 CY2026 Sales
August 06, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 21.4% year on y...
Via
StockStory
Earnings To Watch: Privia Health (PRVA) Reports Q2 Results Tomorrow
August 04, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting earnings this Thursday morning. Here’s what investors should know. Privia Health ...
Via
StockStory
3 Reasons to Avoid PRVA and 1 Stock to Buy Instead
July 24, 2026
Since January 2026, Privia Health has been in a holding pattern, posting a small return of 3.6% while floating around $24.97. Is there a buying opportunity i...
Via
StockStory
Topics
Supply Chain
1 Cash-Heavy Stock to Target This Week and 2 We Ignore
July 16, 2026
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...
Via
StockStory
3 Small-Cap Stocks with Open Questions
July 15, 2026
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via
StockStory
What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors?
↗
July 12, 2026
This healthcare services provider, focused on value-based care, reported a notable insider sale amid a year of double-digit stock gains.
Via
The Motley Fool
Topics
Regulatory Compliance
3 Cash-Producing Stocks with Open Questions
July 03, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
June 19, 2026
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via
StockStory
3 Stocks Under $50 That Fall Short
June 11, 2026
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...
Via
StockStory
Topics
Regulatory Compliance
Privia's CEO Just Sold 121,000 Shares for $2.7 Million
↗
June 08, 2026
This healthcare technology firm supporting independent physicians reported a notable insider sale.
Via
The Motley Fool
Topics
Derivatives
Regulatory Compliance
Q1 Rundown: Privia Health (NASDAQ:PRVA) Vs Other Healthcare Technology for Providers Stocks
June 04, 2026
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking a...
Via
StockStory
3 Russell 2000 Stocks with Open Questions
June 04, 2026
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ...
Via
StockStory
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?
↗
May 30, 2026
Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide.
Via
The Motley Fool
Topics
Regulatory Compliance
1 Healthcare Stock with Competitive Advantages and 2 We Brush Off
May 11, 2026
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de...
Via
StockStory
Privia Health Group Q1 Earnings Call Highlights
↗
May 08, 2026
Privia Health Group (NASDAQ:PRVA) reported a strong first quarter, with executives pointing to double-digit provider growth, a larger value-based care population and margin expansion as signs that the...
Via
MarketBeat
Topics
Earnings
Privia Health (PRVA) Q1 2026 Earnings Transcript
↗
May 08, 2026
Privia Health (PRVA) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Artificial Intelligence
Privia Health (NASDAQ:PRVA) Posts Better-Than-Expected Sales In Q1 CY2026
May 07, 2026
Healthcare tech company Privia Health Group (NASDAQ:PRVA) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 25.8% year on ...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
Next >
